Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,030 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.
Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, Masunari T, Yoshida I, Moro H, Nikkuni K, Takai K, Matsue K, Kurosawa M, Hagihara M, Saito A, Okamoto M, Yokota K, Hiraiwa S, Nakamura N, Nakao S, Yoshino T, Sato Y. Iwaki N, et al. Among authors: takai k. Am J Hematol. 2016 Feb;91(2):220-6. doi: 10.1002/ajh.24242. Am J Hematol. 2016. PMID: 26805758 Free article.
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S. Masaki Y, et al. Among authors: takai k. Int J Hematol. 2016 Jun;103(6):686-92. doi: 10.1007/s12185-016-1979-1. Epub 2016 Mar 18. Int J Hematol. 2016. PMID: 27084250
Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y. Kawabata H, et al. Among authors: takai k. J Clin Exp Hematop. 2013;53(1):57-61. doi: 10.3960/jslrt.53.57. J Clin Exp Hematop. 2013. PMID: 23801135 Free article.
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
Furukawa T, Narita M, Koike T, Takai K, Nagai K, Kobayashi M, Koyama S, Seki Y, Takahashi H, Fujiwara M, Kishi K, Nikkuni K, Isahai N, Higuchi W, Nomoto N, Maruyama S, Masuko M, Kuroha T, Abe T, Toba K, Takahashi M, Aizawa Y, Shibata A. Furukawa T, et al. Among authors: takai k. Int J Hematol. 2011 Mar;93(3):336-343. doi: 10.1007/s12185-011-0774-2. Epub 2011 Feb 5. Int J Hematol. 2011. PMID: 21293953 Clinical Trial.
1,030 results